Adam Hansard, Chief Commercial Officer at Applied Therapeutics Inc. (APLT), sold 9,720 shares at $2.70 ($26K) on 2023-09-27, disclosed to the SEC on 2023-09-29.
Open-market sale of $26k APLT by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APLT | SELL | 2023-01-13 | $4K | — | Filing → |
| APLT | SELL | 2021-05-28 | $106K | — | Filing → |